TrialBMC dermatology2016

Randomized placebo control study of insulin sensitizers (Metformin and Pioglitazone) in psoriasis patients with metabolic syndrome (Topical Treatment Cohort).

Surjit Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.